Alnylam vet Smith joins MPM

MPM Capital has added Pete Smith to its team of entrepreneurs. Smith was chief early development officer at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and SVP, head of R&D non-clinical at Moderna Inc. (NASDAQ:MRNA).

Mark Bodenrader, VP of finance and chief accounting officer of neuroscience company Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) will serve as interim CFO following the resignation of Kathy Yi, who is pursuing other opportunities. Yi will remain with the company until Nov. 15...